INDEMNIFICATION AGREEMENTIndemnification Agreement • May 15th, 2003 • Transkaryotic Therapies Inc • Biological products, (no disgnostic substances) • Delaware
This Agreement is made as of the 30th day of April 2003, by and between Transkaryotic Therapies, Inc., a Delaware corporation (the “Corporation”), and Michael J. Astrue (the “Indemnitee”), a director and an officer of the Corporation.
INDEMNIFICATION AGREEMENTIndemnification Agreement • May 15th, 2003 • Transkaryotic Therapies Inc • Biological products, (no disgnostic substances)
This Agreement is made as of the 13th day of March 2003, by and between Transkaryotic Therapies, Inc., a Delaware corporation (the “Corporation”), and Daniel E. Geffken (the “Indemnitee”), an officer of the Corporation.
RETENTION AGREEMENTRetention Agreement • May 15th, 2003 • Transkaryotic Therapies Inc • Biological products, (no disgnostic substances) • Massachusetts
This Retention Agreement is made as of March 13, 2003 by and between Transkaryotic Therapies, Inc., a Delaware company (the “Company”), and Daniel E. Geffken (the “Executive”).
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions.License Agreement • May 15th, 2003 • Transkaryotic Therapies Inc • Biological products, (no disgnostic substances)
WOMEN’S AND CHILDREN’S HOSPITAL, a non-profit institution incorporated in South Australia and of 72 King William Road, North Adelaide, South Australia (“Licensor”);
EMPLOYMENT AGREEMENTEmployment Agreement • May 15th, 2003 • Transkaryotic Therapies Inc • Biological products, (no disgnostic substances) • Massachusetts
AGREEMENT, dated as of April 30, 2003, between Transkaryotic Therapies, Inc., a Delaware corporation (the “Company”), and Michael J. Astrue (the “Executive”).
